Agena Bioscience Announces Collaboration with PerkinElmer

21 August 2018 Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy Workflow San Diego, CA – Agena Bioscience (Agena) announced today that they have entered into a collaboration with PerkinElmer, incorporating the LabChip® GX Touch™ nucleic acid analyzer for quality assessment and quantitation of DNA in the upfront workflow of Agena’s MassARRAY®system. The... Read more

IsoPlexis Announces Expansion into Asia Pacific

IsoPlexis expands sales of its single-cell proteomic analysis platform, IsoLight and IsoCode Chip, to the pharmaceutical and life sciences markets in China BRANFORD, Conn., Aug. 20, 2018 /PRNewswire/ — IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today an exclusive agreement with Tekon Biotech, a leading instrumentation distributor, to... Read more

Diagenode Announces Acquisition of Service Provider NXT-Dx to Complement Epigenetics Assay Services

Monday, August 20, 2018 New acquisition rounds out Diagenode’s epigenomics profiling services platform DENVILLE, N.J. AND LIEGE, BELGIUM (PRWEB) AUGUST 16, 2018 Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety of start-to-finish epigenetics services including a number of targeted DNA methylation assays using... Read more

QIAGEN partners with The Scientific Group to expand commercial presence in Africa

Hilden, Germany, and Johannesburg, South Africa, August 20, 2018 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the appointment of The Scientific Group, a South Africa-based company and wholly owned subsidiary of Ascendis Medical, as its exclusive commercial partner for Africa, excluding South Africa and the Maghreb. The agreement will raise the profile... Read more

Agilent Completes Acquisition of Young In Scientific Co. Ltd. Assets

Agilent Completes Acquisition of Young In Scientific Co. Ltd. Assets SANTA CLARA, Calif., Aug 17, 2018 Agilent Technologies Inc. (NYSE: A) today announced that it has completed its acquisition of the Agilent-related business from Young In Scientific Co. Ltd. and its affiliates (“YI Scientific”). YI Scientific is a leading distributor of analytical and scientific instruments... Read more

Tecan accelerates broad genomics strategy with the acquisition of NuGEN Technologies

August 16, 2018 Acquisition of US-based NuGEN expands Tecan’s dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits and genomic sample prep reagents for the fastest growing field within the genomics area NuGEN to become part of Tecan’s Life Sciences Business, leveraging Tecan’s... Read more

Elsevier to Acquire Aries Systems, A Best-in-class Publication Workflow Solutions Provider

New York, August 2, 2018 Elsevier, the global information analytics business specializing in science and health, today announced it has signed a definitive agreement to acquire Aries Systems, a leader in scientific publication workflow solutions headquartered outside Boston, MA. Aries’ offerings are used by journals, books and other publications for manuscript submission, peer review, production tracking... Read more

Neogen acquires water microbiology testing technology

CONTACT: Steven J. Quinlan, Vice President & CFO, Neogen Corporation, 517/372-9200 LANSING, Mich., Aug. 1, 2018 — Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired Clarus Labs, Inc. The acquisition provides Neogen products, and greater access to the $400 million global water microbiology testing market. The acquisition includes the patented Colitag™ water test, which... Read more

Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc.

AUGUST 01, 2018 MINNEAPOLIS, Aug.1, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Exosome Diagnostics, Inc. The transaction consideration includes an upfront payment of $250 million plus an additional $325 million that can be maximally earned through calendar year 2022 upon reaching certain performance milestones. With this acquisition, Minneapolis-based... Read more